UNSPSC 51202805: Tacrolimus anhydrous

This classification denotes a mtor inhibitor and immunosuppressant with the molecular formula C44H69NO12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y5L2157C4J, chemically known as tacrolimus, anhydrous, but more generally known as tacrolimus anhydrous, which bears US NIH Compound Identifier 6436007. European Medicines Agency schedules tacrolimus anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10797MIG.

Most nations, for tariff purposes, schedule tacrolimus anhydrous under HS 29349990. Tacrolimus anhydrous bears US NLM identifiers UMLS ID C0771204 and NCI Concept Code C76066. SMILES: C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC.

UNSPSC 51202805 Tacrolimus anhydrous is a Commodity code that nominally identifies a single immunosuppressant pharmaceutical product, yet recent state and local solicitations tagged with this code show minimal alignment with tacrolimus procurement itself. Instead, the opportunities posted under it span broader pharmaceutical and medical supply categories: generic multi-source drugs and over-the-counter products, direct-to-manufacturer prescription programs, naloxone and drug deactivation systems, and fire-rescue medical consumables. The mismatch between the code's nominal scope and what is actually being solicited suggests either tagging inconsistencies in state and local procurement systems or that tacrolimus represents a placeholder or gateway code for wider pharmaceutical purchasing. State and local issuing bodies using this code include county health departments, state health and human services commissions, city fire departments, and cooperative purchasing alliances that serve multiple states.

Geographic activity centers on Florida, Texas, and Minnesota, with cooperative procurement in Oregon. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802) on January 20, 2026, due March 26, 2026, seeking manufacturers of generic multi-source pharmaceuticals and OTC products for distribution across state and local facilities, with awarded vendors required to supply through authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act standards. The Texas Health and Human Services Commission posted an RFI (HHS0017013) on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription fulfillment capabilities outside traditional pharmacy benefit managers and group purchasing organizations. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, due July 26, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives with quarterly deliveries to the county health building. The City of Tampa's Purchasing Department solicited sealed bids (26-P-00145) due March 13, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a Small Local Business Enterprise set-aside.